BNED
Barnes & Noble Education, Inc.
BNED has a slight edge over LCID overall, supported by lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BNED Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Healthy |
BNED's balance sheet is currently healthy, and its revenue, profitability and cash flow are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BNED PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $11.71 | -7.8% |
| Current | 19x | $12.70 | — |
| Fair | 20x | $13.51 | +6.4% |
| Expensive | 26x | $16.96 | +34% |
Historical ranges are pointers, not guarantees.
BNED's PE is 19x, but its earnings don't support one, so it isn't a reliable read right now.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BNED Forward outlook
There aren't enough analyst estimates for BNED to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BNED Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.66 | -25% |
| Q2 2026 | $0.49 | +$6.43 |
| Q1 2024 | -$156.00 | -$31.00 |
| Q4 2023 | -$186.00 | -$38.00 |
| Q3 2023 | -$190.00 | -$41.00 |
| Q2 2023 | -$195.00 | -$61.00 |
| Q1 2023 | -$125.00 | +$79.00 |
| Q4 2022 | -$148.00 | +$81.00 |
BNED has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BNED Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $290.6M | +0.8% |
| Q2 2026 | $267.1M | -5.2% |
| Q1 2026 | $515.1M | +10% |
| Q4 2025 | $644.4M | +7% |
| Q3 2025 | $288.2M | +9.4% |
| Q2 2025 | $281.8M | +19% |
| Q1 2025 | $466.3M | +2.1% |
| Q4 2024 | $602.1M | -1.4% |
BNED's revenue has picked up after three years of holding roughly level: $291M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.9% | +2.1 points |
| Q2 2026 | 1.6% | +5.7 points |
| Q1 2026 | 2.8% | -2.1 points |
| Q4 2025 | 6.3% | -3 points |
| Q3 2025 | -8% | +27 points |
| Q2 2025 | -4% | +3.1 points |
| Q1 2025 | 4.9% | +4.7 points |
| Q4 2024 | 9.3% | +3.5 points |
BNED has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BNED on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BNED Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$56.4M | +$14.9M |
| Q2 2026 | $76.4M | +54% |
| Q1 2026 | -$33.1M | +$11.6M |
| Q4 2025 | $61.9M | +40% |
| Q3 2025 | -$71.3M | +$76.1M |
| Q2 2025 | $49.5M | -37% |
| Q1 2025 | -$44.7M | -$5.7M |
| Q4 2024 | $44.4M | -35% |
BNED has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BNED Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 0.9x | Very low |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 6.8x | High |
| Q1 2025 | 13.4x | High |
| Q2 2024 | 10.0x | High |
BNED's net debt is about 1.6 years of its operating earnings (EBITDA), down from 2.1 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BNED Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.9 | Neutral |
| Stochastic | 62.1 | Neutral |
BNED's weekly RSI is 56 (neutral) and its Stochastic is 62 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BNED PE vs Consumer Cyclical Sector
| Metric | BNED | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 6.8% above |
BNED is trading at 19x earnings, in line with the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BNED Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.5 | 1.6% above |
| 20 week MA | $12.3 | 3.4% above |
| 50 week MA | $10.6 | 20% above |
| 100 week MA | $10.2 | 24% above |
| 200 week MA | $50.4 | 75% below |
BNED has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BNED Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $417.0 | $508.0 | +22% |
| 2021 | $508.0 | $669.0 | +32% |
| 2022 | $669.0 | $159.0 | -76% |
| 2023 | $159.0 | $149.0 | -6.3% |
| 2024 | $149.0 | $10.3 | -93% |
| 2025 | $10.3 | $9.65 | -6.2% |
| 2026 YTD | $9.65 | $12.7 | +32% |
BNED has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.